Related references
Note: Only part of the references are listed.Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Peter J. Goadsby et al.
BRAIN (2019)
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States
Machaon Bonafede et al.
HEADACHE (2018)
Glutamate and Its Receptors as Therapeutic Targets for Migraine
Jan Hoffmann et al.
NEUROTHERAPEUTICS (2018)
Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?
Eloisa Rubio-Beltran et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom
Pamela Vo et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Lasmiditan is an effective acute treatment for migraine A phase 3 randomized study
Bernice Kuca et al.
NEUROLOGY (2018)
A human trigeminovascular biomarker for antimigraine drugs: A randomised, double-blind, placebo-controlled, crossover trial with sumatriptan
K. Ibrahimi et al.
CEPHALALGIA (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine
Smriti Iyengar et al.
PAIN (2017)
PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING
Peter J. Goadsby et al.
PHYSIOLOGICAL REVIEWS (2017)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine
Tony W. Ho et al.
CEPHALALGIA (2016)
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Tiffini Voss et al.
CEPHALALGIA (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response
Matilde Capi et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Andrew F. Russo
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Can aging be 'drugged'?
Celine E. Riera et al.
NATURE MEDICINE (2015)
Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine
Richard B. Lipton et al.
NEUROLOGY (2015)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho et al.
NEUROLOGY (2014)
Vasodilation out of the picture as a cause of migraine headache
Andrew Charles
LANCET NEUROLOGY (2013)
Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study
Faisal Mohammad Amin et al.
LANCET NEUROLOGY (2013)
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
Eva Cernuda-Morollon et al.
NEUROLOGY (2013)
Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators
Peer Tfelt-Hansen et al.
CEPHALALGIA (2012)
Nucleotide Excision DNA Repair Is Associated With Age-Related Vascular Dysfunction
Matej Durik et al.
CIRCULATION (2012)
A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
B. R. Chaitman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
Tony W. Ho et al.
HEADACHE (2012)
Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
Markus Farkkila et al.
LANCET NEUROLOGY (2012)
mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system
Dipak V. Amrutkar et al.
PAIN (2012)
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression
Alessandro Tozzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
Hans-Christoph Diener et al.
CEPHALALGIA (2011)
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
David J. Hewitt et al.
CEPHALALGIA (2011)
The 5-HT1 receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: Further involvement of 5-HT1F, but not 5-HT1A or 5-HT1D, subtypes
Abimael Gonzalez-Hernandez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
Kathryn M. Connor et al.
HEADACHE (2011)
Antimigraine Efficacy of Telcagepant Based on Patient's Historical Triptan Response
Tony W. Ho et al.
HEADACHE (2011)
Randomized Controlled Study of Telcagepant Plus Ibuprofen or Acetaminophen in Migraine
David J. Hewitt et al.
HEADACHE (2011)
Effect of Telcagepant on Spontaneous Ischemia in Cardiovascular Patients in a Randomized Study
Martin O. Behm et al.
HEADACHE (2011)
Cortical Projections of Functionally Identified Thalamic Trigeminovascular Neurons: Implications for Migraine Headache and Its Associated Symptoms
Rodrigo Noseda et al.
JOURNAL OF NEUROSCIENCE (2011)
CGRP Sensory neuropeptide with multiple neurologic implications
Eduardo E. Benarroch
NEUROLOGY (2011)
Preclinical pharmacological profile of the selective 5-HTIF receptor agonist lasmiditan
David L. Nelson et al.
CEPHALALGIA (2010)
Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
Michel D. Ferrari et al.
CEPHALALGIA (2010)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
Health-Related Quality of Life, Disability and Severity of Disease in Patients With Migraine Attending to a Specialty Headache Center
Matilde Leonardi et al.
HEADACHE (2010)
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
D. C. Buse et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Employment and Work Impact of Chronic Migraine and Episodic Migraine
Walter F. Stewart et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2010)
Current practice and future directions in the prevention and acute management of migraine
Peter J. Goadsby et al.
LANCET NEUROLOGY (2010)
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
Sajedeh Eftekhari et al.
Therapeutic Advances in Neurological Disorders (2010)
The vascular theory of migrainea great story wrecked by the facts
Peter J. Goadsby
BRAIN (2009)
The acute treatment of episodic and chronic migraine in the USA
M. E. Bigal et al.
CEPHALALGIA (2009)
Neurons of the Dopaminergic/Calcitonin Gene-Related Peptide A11 Cell Group Modulate Neuronal Firing in the Trigeminocervical Complex: An Electrophysiological and Immunohistochemical Study
Annabelle R. Charbit et al.
JOURNAL OF NEUROSCIENCE (2009)
Randomized, controlled trial of telcagepant for the acute treatment of migraine
K. M. Connor et al.
NEUROLOGY (2009)
Migraine headache is not associated with cerebral or meningeal vasodilatation - a 3T magnetic resonance angiography study
G. G. Schoonman et al.
BRAIN (2008)
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine
A. Rahmann et al.
CEPHALALGIA (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Neuron-glia signaling in trigeminal ganglion: Implications for migraine pathology
Srikanth Thalakoti et al.
HEADACHE (2007)
Satisfaction with current migraine therapy: Experience from 3 centers in US and Sweden
Marcelo Bigal et al.
HEADACHE (2007)
Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion
Zhongming Zhang et al.
JOURNAL OF NEUROSCIENCE (2007)
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine
David W. Dodick et al.
CNS DRUGS (2007)
Neurogenic inflammation and migraine: Implications for therapeutics
SJ Peroutka
MOLECULAR INTERVENTIONS (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation
Razzaque et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
5-HT1F receptor agonists in acute migraine treatment:: a hypothesis
NM Ramadan et al.
CEPHALALGIA (2003)
Evidence for serotonin (5-HT)(1B), 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input
PJ Goadsby et al.
NEUROSCIENCE (2003)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine:: a randomised controlled trial
DJ Goldstein et al.
LANCET (2001)
Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries
J Bou et al.
CEPHALALGIA (2001)
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine
B Gomez-Mancilla et al.
CEPHALALGIA (2001)
Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels
RWM van den Broek et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
H Doods et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
